EP1885187
Aðferðir til meðhöndla lyfjaþolið krabbamein
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
10.5.2006EP published:
25.9.2013EP application number:
06752445.4
EP translation filed:
5.11.2013Grant published:
15.11.2013EPO information:
European Patent Register
Max expiry date:
9.5.2026Expiry date:
9.5.2017
Title:
METHODS FOR TREATING DRUG RESISTANT CANCER
Timeline
Today
10.5.2006EP application
25.9.2013EP Publication
5.11.2013Translation submitted
15.11.2013Registration published
9.5.2017Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
MICHELSON, Glenn C.Address:
Emeryville,California, US
Name:
CHAN, Vivien W.Address:
Emeryville,California, US
Name:
HEISE, Carla C.Address:
Emeryville,California, US
Name:
WIESMANN, MarionAddress:
Emeryville,California, US
Name:
DAWES, Timothy D.Address:
Emeryville,California, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
680722 PDate:
13.5.2005Country:
US
Classification
Categories:
A61K 31/4184, A61K 31/4425, A61K 31/497, A61K 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 9.4.2014
Expires: 9.5.2015
Payer: Árnason Faktor
Number: 10
Paid: 9.4.2015
Expires: 9.5.2016
Payer: Árnason Faktor
Number: 11
Paid: 12.4.2016
Expires: 9.5.2017
Payer: Árnason Faktor